BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 5454342)

  • 21. Isoniazid induced neuropathy in slow versus rapid acetylators: an electrophysiological study.
    Goel UC; Bajaj S; Gupta OP; Dwivedi NC; Dubey AL
    J Assoc Physicians India; 1992 Oct; 40(10):671-2. PubMed ID: 1339149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.
    Olsen H; Mørland J
    Br Med J; 1978 Nov; 2(6147):1260-2. PubMed ID: 709306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carry-over of sulphadimidine in the faeces and urine of pigs fed medicated feed.
    McCaughey WJ; Elliott CT; Crooks SR
    Vet Rec; 1990 Apr; 126(15):351-4. PubMed ID: 2336779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoniazid phenotyping in Munda and Oraon tribes of Chhotanagpur division suffering from pulmonary tuberculosis by sulphadimidine acetylation test.
    Sinha CP; Sinha S; Sinha KP; Choudhary KD
    Indian J Med Sci; 1980 Aug; 34(8):189-92. PubMed ID: 7203584
    [No Abstract]   [Full Text] [Related]  

  • 26. Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.
    SELKON JB; FOX W; GANGADHARAM PR; RAMACHANDRAN K; RAMAKRISHNAN CV; VELU S
    Bull World Health Organ; 1961; 25(6):779-92. PubMed ID: 13910443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):111-4. PubMed ID: 2318546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylation pattern of different sulphonamides in rapid and slow isoniazid inactivators.
    Mattila MJ; Tiitinen H; Alhava E
    Ann Med Exp Biol Fenn; 1969; 47(4):308-15. PubMed ID: 5384058
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose-dependent changes in sulfamethazine kinetics in rapid and slow isoniazid acetylators.
    Olson W; Miceli J; Weber W
    Clin Pharmacol Ther; 1978 Feb; 23(2):204-11. PubMed ID: 620482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-acetylation of drugs: search for INH acetylation polymorphism in baboons.
    Radtke HE; Brenner W; Weber WW
    Drug Metab Dispos; 1979; 7(3):194-5. PubMed ID: 38093
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
    Hall S
    Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylation of sulphadimidine in calves.
    Lapka R; Urbanová Z; Rasková H; Cerný J; Sýkora Z; Vanĕcek J; Polák L; Kubícek A
    Gen Pharmacol; 1980; 11(1):147-8. PubMed ID: 7364198
    [No Abstract]   [Full Text] [Related]  

  • 33. Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.
    GANGADHARAM PR; BHATIA AL; RADHAKRISHNA S; SELKON JB
    Bull World Health Organ; 1961; 25(6):765-77. PubMed ID: 13896634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.
    Jeanes CW; Schaefer O; Eidus L
    Can Med Assoc J; 1973 Sep; 109(6):483-7. PubMed ID: 4742916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intra-articular glucocorticoids on the disposition of sulphadimidine in chronic osteoarthritis patients.
    Reeves PT; Hanrahan P; Edelman J; Ilett KF
    Br J Clin Pharmacol; 1988 Nov; 26(5):563-8. PubMed ID: 3207561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
    Balakrishnan S; Ramu G
    Lepr India; 1977 Jan; 49(1):59-64. PubMed ID: 330945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of sulphadimidine (sulphamezathine) in patients with renal failure.
    Adam WR; Brown DJ; Hales P; Dawborn JK
    Med J Aust; 1973 May; 1(19):936-8. PubMed ID: 4715400
    [No Abstract]   [Full Text] [Related]  

  • 39. An improved and simplified method of detecting the acetylator phenotype.
    Evans DA
    J Med Genet; 1969 Dec; 6(4):405-7. PubMed ID: 5365949
    [No Abstract]   [Full Text] [Related]  

  • 40. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Tubercle; 1972 Jun; 53(2):84-91. PubMed ID: 5040582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.